36 related articles for article (PubMed ID: 38757129)
1. The role of green tea intake in thromboprophylaxis of venous thromboembolism in patients with cancer.
Yao Q; Qiao H; Cheng Y; Du H; Zhang Y; Luo Y; Wang H; Liu S; Xu M; Xiong W
Front Nutr; 2024; 11():1296774. PubMed ID: 38757129
[TBL] [Abstract][Full Text] [Related]
2. Immobility-associated thromboprotection is conserved across mammalian species from bear to human.
Thienel M; Müller-Reif JB; Zhang Z; Ehreiser V; Huth J; Shchurovska K; Kilani B; Schweizer L; Geyer PE; Zwiebel M; Novotny J; Lüsebrink E; Little G; Orban M; Nicolai L; El Nemr S; Titova A; Spannagl M; Kindberg J; Evans AL; Mach O; Vogel M; Tiedt S; Ormanns S; Kessler B; Dueck A; Friebe A; Jørgensen PG; Majzoub-Altweck M; Blutke A; Polzin A; Stark K; Kääb S; Maier D; Gibbins JM; Limper U; Frobert O; Mann M; Massberg S; Petzold T
Science; 2023 Apr; 380(6641):178-187. PubMed ID: 37053338
[TBL] [Abstract][Full Text] [Related]
3. Genetically predicted green tea intake and the risk of arterial embolism and thrombosis.
Jia L; Chen Y; Liu C; Luan Y; Jia M
Front Med (Lausanne); 2023; 10():1156254. PubMed ID: 37035310
[TBL] [Abstract][Full Text] [Related]
4. An undefined cystatin CsCPI1 from tea plant Camellia sinensis harbors antithrombotic activity.
Fang M; Cha JH; Wang HC; Ye P; Chen B; Chen M; Yang WH; Yan X
Biomed Pharmacother; 2023 Mar; 159():114285. PubMed ID: 36706630
[TBL] [Abstract][Full Text] [Related]
5. Acute Pulmonary Embolism: A Review.
Freund Y; Cohen-Aubart F; Bloom B
JAMA; 2022 Oct; 328(13):1336-1345. PubMed ID: 36194215
[TBL] [Abstract][Full Text] [Related]
6. Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG): A Time for a New Player in the Treatment of Respiratory Diseases?
Mokra D; Adamcakova J; Mokry J
Antioxidants (Basel); 2022 Aug; 11(8):. PubMed ID: 36009285
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary Embolism.
Kahn SR; de Wit K
N Engl J Med; 2022 Jul; 387(1):45-57. PubMed ID: 35793208
[No Abstract] [Full Text] [Related]
8. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19.
Farge D; Frere C; Connors JM; Khorana AA; Kakkar A; Ay C; Muñoz A; Brenner B; Prata PH; Brilhante D; Antic D; Casais P; Guillermo Esposito MC; Ikezoe T; Abutalib SA; Meillon-García LA; Bounameaux H; Pabinger I; Douketis J;
Lancet Oncol; 2022 Jul; 23(7):e334-e347. PubMed ID: 35772465
[TBL] [Abstract][Full Text] [Related]
9. Optimal authoritative risk assessment score of Cancer-associated venous thromboembolism for hospitalized medical patients with lung Cancer.
Xiong W; Zhao Y; Du H; Wang Y; Xu M; Guo X
Thromb J; 2021 Dec; 19(1):95. PubMed ID: 34863189
[TBL] [Abstract][Full Text] [Related]
10. Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Streiff MB; Holmstrom B; Angelini D; Ashrani A; Elshoury A; Fanikos J; Fertrin KY; Fogerty AE; Gao S; Goldhaber SZ; Gundabolu K; Ibrahim I; Kraut E; Leavitt AD; Lee A; Lee JT; Lim M; Mann J; Martin K; McMahon B; Moriarty J; Morton C; Ortel TL; Paschal R; Schaefer J; Shattil S; Siddiqi T; Sudheendra D; Williams E; Hollinger L; Nguyen MQ
J Natl Compr Canc Netw; 2021 Oct; 19(10):1181-1201. PubMed ID: 34666313
[TBL] [Abstract][Full Text] [Related]
11. Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes.
Son MBF; Murray N; Friedman K; Young CC; Newhams MM; Feldstein LR; Loftis LL; Tarquinio KM; Singh AR; Heidemann SM; Soma VL; Riggs BJ; Fitzgerald JC; Kong M; Doymaz S; Giuliano JS; Keenaghan MA; Hume JR; Hobbs CV; Schuster JE; Clouser KN; Hall MW; Smith LS; Horwitz SM; Schwartz SP; Irby K; Bradford TT; Maddux AB; Babbitt CJ; Rowan CM; McLaughlin GE; Yager PH; Maamari M; Mack EH; Carroll CL; Montgomery VL; Halasa NB; Cvijanovich NZ; Coates BM; Rose CE; Newburger JW; Patel MM; Randolph AG;
N Engl J Med; 2021 Jul; 385(1):23-34. PubMed ID: 34133855
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism.
Khan F; Tritschler T; Kahn SR; Rodger MA
Lancet; 2021 Jul; 398(10294):64-77. PubMed ID: 33984268
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism in cancer patients: a population-based cohort study.
Mulder FI; Horváth-Puhó E; van Es N; van Laarhoven HWM; Pedersen L; Moik F; Ay C; Büller HR; Sørensen HT
Blood; 2021 Apr; 137(14):1959-1969. PubMed ID: 33171494
[TBL] [Abstract][Full Text] [Related]
14. Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000-18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database.
Barco S; Valerio L; Ageno W; Cohen AT; Goldhaber SZ; Hunt BJ; Iorio A; Jimenez D; Klok FA; Kucher N; Mahmoudpour SH; Middeldorp S; Münzel T; Tagalakis V; Wendelboe AM; Konstantinides SV
Lancet Respir Med; 2021 Jan; 9(1):33-42. PubMed ID: 33058771
[TBL] [Abstract][Full Text] [Related]
15. Warfarin and food, herbal or dietary supplement interactions: A systematic review.
Tan CSS; Lee SWH
Br J Clin Pharmacol; 2021 Feb; 87(2):352-374. PubMed ID: 32478963
[TBL] [Abstract][Full Text] [Related]
16. Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.
Agnelli G; Becattini C; Meyer G; Muñoz A; Huisman MV; Connors JM; Cohen A; Bauersachs R; Brenner B; Torbicki A; Sueiro MR; Lambert C; Gussoni G; Campanini M; Fontanella A; Vescovo G; Verso M;
N Engl J Med; 2020 Apr; 382(17):1599-1607. PubMed ID: 32223112
[TBL] [Abstract][Full Text] [Related]
17. Green tea (Camellia sinensis) for the prevention of cancer.
Filippini T; Malavolti M; Borrelli F; Izzo AA; Fairweather-Tait SJ; Horneber M; Vinceti M
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD005004. PubMed ID: 32118296
[TBL] [Abstract][Full Text] [Related]
18. Using Propensity Score Methods to Create Target Populations in Observational Clinical Research.
Thomas L; Li F; Pencina M
JAMA; 2020 Feb; 323(5):466-467. PubMed ID: 31922529
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
